Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement

Bor Sheng Ko, Cheng Shyong Chang, Ming Chih Chang, Tsai Yun Chen, Tzeon Jye Chiou, Chang Fang Chiu, Wen Li Huang, Woei Yau Kao, Yii Jenq Lan, Shen Fung Lin, Tran Der Tan, Jih Luh Tang, Cheng Hwai Tzeng, Po Nan Wang, Su Pen Yet, Hwei Fang Tien

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)

Abstract

Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalInternational Journal of Hematology
Volume100
Issue number1
DOIs
Publication statusPublished - 2014 Jul

All Science Journal Classification (ASJC) codes

  • Hematology

Fingerprint Dive into the research topics of 'Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement'. Together they form a unique fingerprint.

Cite this